During the Dutch Life Sciences conference in Leiden, the founders of STENTiT pitched their business plan to a group of life science investors. Among the nine candidates, STENTiT was unanimously chosen by the jury as the winner of the Investors Forum. In addition, STENTiT presented the case in front of a large audience during the plenary closing ceremony.
The STENTiT regenerative stent will be the only device on the market that brings vascular regeneration to the patient without requiring invasive surgical procedures. Made out of a fully biodegradable porous structure, the product provides minimally-invasive support to the diseased artery and promotes natural vascular regeneration using the patient’s circulating blood cells.
More about STENTiT check their website at www.stentit.com